BNP PARIBAS FINANCIAL MARKETS - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$112,595
-48.7%
67,021
-13.7%
0.00%
Q2 2023$219,659
-28.5%
77,618
+24.1%
0.00%
Q1 2023$307,062
+118.1%
62,538
+377.1%
0.00%
Q4 2022$140,791
-100.0%
13,109
-62.8%
0.00%
-100.0%
Q3 2022$329,640,000
+58.6%
35,218
+54.7%
0.00%
Q2 2022$207,799,000
-48.4%
22,760
-31.3%
0.00%
-100.0%
Q1 2022$402,554,000
-9.0%
33,132
-8.8%
0.00%0.0%
Q4 2021$442,378,000
-48.4%
36,320
-34.6%
0.00%0.0%
Q3 2021$857,614,000
+90.8%
55,509
+76.2%
0.00%0.0%
Q2 2021$449,562,000
+26.5%
31,504
+92.5%
0.00%0.0%
Q1 2021$355,262,000
+81.6%
16,364
+26.6%
0.00%
Q4 2020$195,586,000
+60.7%
12,927
+35.1%
0.00%
Q3 2020$121,740,000
+382.3%
9,567
+548.2%
0.00%
Q2 2020$25,240,000
-84.6%
1,476
-88.1%
0.00%
Q1 2020$163,527,000
+115.4%
12,379
+162.7%
0.00%
Q4 2019$75,910,000
-30.3%
4,712
-20.9%
0.00%
Q3 2019$108,857,000
+39.2%
5,955
+63.7%
0.00%
Q2 2019$78,196,000
-41.2%
3,637
-46.3%
0.00%
Q1 2019$132,984,000
+102195.4%
6,778
+67680.0%
0.00%
Q4 2018$130,000
-99.4%
10
-98.9%
0.00%
Q3 2018$21,124,000
+14.3%
882
-8.6%
0.00%
Q2 2018$18,480,000
-73.8%
965
-83.1%
0.00%
Q1 2018$70,541,000
+4.8%
5,698
+3.6%
0.00%
Q4 2017$67,296,000
+114.2%
5,498
+139.6%
0.00%
Q3 2017$31,419,000
-16.7%
2,295
-6.4%
0.00%
Q2 2017$37,721,000
+9213.8%
2,451
+11040.9%
0.00%
Q1 2017$405,000
-72.6%
22
-86.2%
0.00%
Q4 2016$1,477,000
-87.2%
159
-88.5%
0.00%
Q3 2016$11,573,000
+205.0%
1,386
+75.7%
0.00%
Q2 2016$3,795,000
-94.1%
789
-79.5%
0.00%
Q4 2015$64,742,000
+13.3%
3,840
-4.0%
0.00%
Q3 2015$57,131,000
+238.5%
3,998
+187.8%
0.00%
Q2 2015$16,876,000
+1162.2%
1,389
+944.4%
0.00%
Q1 2015$1,337,000
+34.0%
133
+11.8%
0.00%
Q3 2014$998,000
-80.2%
119
-59.8%
0.00%
Q2 2014$5,038,0002960.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders